Kangbo Medical-B (02216.HK) announced its interim financial results, with a net loss of 7.792 million US dollars, a year-on-year decrease of 1.9%.

The Zhitong Finance and Economics APP news reported that Conbo Medical-B (02216.HK) released its interim performance for the six months ending June 30, 2025. The group's revenue was 1.652 million US dollars, a year-on-year decrease of 55.4%; net loss was 7.792 million US dollars, a year-on-year narrowing of 1.9%; gross profit was 1.214 million US dollars, a year-on-year decrease of 58.9%.